Department of Gastroenterology, Norfolk and Norwich University Hospital, Norwich, UK.
Division of Gastroenterology, Department of Medicine, Addenbrooke's Hospital, University of Cambridge, Cambridge, UK.
Acta Paediatr. 2017 Nov;106(11):1729-1741. doi: 10.1111/apa.13902. Epub 2017 Jun 9.
UNLABELLED: We performed an updated meta-analysis incorporating the results of recent randomised controlled trials (RCTs) to measure the effectiveness of probiotic supplementation in preventing necrotising enterocolitis (NEC) and death in very low-birth-weight (VLBW) infants, and to investigate any differences in efficacy by probiotic agent. Using meta-regression analysis, we assessed the contribution of other measured variables on the overall effect size and between-study variability. CONCLUSION: Overall, probiotics lead to significant reductions in NEC incidence and mortality in VLBW infants. Differences in probiotic agents and the influence of prenatal steroids and feeding regimens may explain the differences in outcomes between studies.
目的:我们进行了一项更新的荟萃分析,纳入了最近的随机对照试验(RCT)的结果,以衡量益生菌补充剂在预防极低出生体重(VLBW)婴儿坏死性小肠结肠炎(NEC)和死亡方面的有效性,并研究益生菌制剂的疗效差异。我们使用荟萃回归分析评估了其他测量变量对总效应大小和研究间变异性的贡献。 结论:总体而言,益生菌可显著降低 VLBW 婴儿 NEC 的发生率和死亡率。益生菌制剂的差异以及产前类固醇和喂养方案的影响可能解释了研究结果之间的差异。
Cochrane Database Syst Rev. 2017-8-30
Cochrane Database Syst Rev. 2022-3-1
Cochrane Database Syst Rev. 2022-1-20
Cochrane Database Syst Rev. 2021-8-24
Cochrane Database Syst Rev. 2008-4-16
J Pediatr Gastroenterol Nutr. 2007-11
Cochrane Database Syst Rev. 2008-1-23
Clin Perinatol. 2025-3
Biosci Microbiota Food Health. 2024
Asia Pac J Clin Nutr. 2024-6